Back to All Events

Uveal Melanoma in 2026: What Do We Know and What’s Ahead of Us?

Join Prof. Carol Shields, Director of the Ocular Oncology Service at Wills Eye Hospital, for a compelling seminar on the evolving landscape of uveal melanoma. From identifying high-risk choroidal nevi to understanding the genetic underpinnings of this rare ocular cancer, Dr. Shields offers a comprehensive overview of current diagnostics and treatments. She’ll share insights into minimizing radiation complications and explore cutting-edge developments in liquid biopsies and biomarkers. Discover how neoadjuvant trials are paving the way for metastasis prevention and why telehealth is becoming a vital tool in ocular oncology. This session offers valuable perspectives for clinicians, researchers, and students alike.

Registration URL Join the webinar

Time converter at worldtimebuddy.com
Previous
Previous
July 22

Shields Oncology Rounds

Next
Next
September 26

Benefits and Challenges of Early Detection and Treatment of Uveal Melanoma